Edition:
United States

Corium International Inc (CORI.OQ)

CORI.OQ on NASDAQ Stock Exchange Global Market

9.16USD
20 Jun 2018
Change (% chg)

$-0.07 (-0.76%)
Prev Close
$9.23
Open
$9.30
Day's High
$9.56
Day's Low
$9.16
Volume
55,554
Avg. Vol
91,556
52-wk High
$13.93
52-wk Low
$6.97

Chart for

About

Corium International, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products. As of September 30, 2016, the Company had multiple programs in preclinical and clinical development focused primarily on the treatment of neurological... (more)

Overall

Beta: 1.55
Market Cap(Mil.): $337.55
Shares Outstanding(Mil.): 36.14
Dividend: --
Yield (%): --

Financials

  CORI.OQ Industry Sector
P/E (TTM): -- 29.73 33.88
EPS (TTM): -1.65 -- --
ROI: -68.25 13.68 13.21
ROE: -299.67 15.46 15.18

BRIEF-Corium International Reports Q2 Revenue $10.1 Mln

* CORIUM REPORTS SECOND QUARTER FISCAL 2018 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

May 14 2018

BRIEF-RTW Investments Reports Passive Stake Of 5.29% In Corium International

* RTW INVESTMENTS, LP REPORTS A PASSIVE STAKE OF 5.29 PERCENT IN CORIUM INTERNATIONAL AS OF MARCH 1 - SEC FILING Source text : [http://bit.ly/2H6OFIe] Further company coverage:

Mar 05 2018

BRIEF-Corium Reports Q1 Loss Per Share $0.37

* CORIUM REPORTS FIRST QUARTER FISCAL 2018 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

Feb 08 2018

Earnings vs. Estimates